Scientists probe genetic secrets of superbug to outsmart last-resort antibiotic
NCT ID NCT07475429
First seen Mar 20, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study looks at how certain genes in a dangerous, drug-resistant bacterium (carbapenem-resistant hypervirulent Klebsiella pneumoniae) affect its response to a powerful antibiotic called cefiderocol. Researchers will collect 100 samples from infected patients and test the bacteria's genes and antibiotic sensitivity in the lab. The goal is to understand why some strains resist treatment, which could help doctors choose better therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOLATION AND IDENTIFICATION OF CARBAPENEM-RESISTANT HYPERVIRULENT K. PNEUMONIAE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Medicine
Sohag, Egypt
Conditions
Explore the condition pages connected to this study.